Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Enrolling by invitation · Phase 3
Conditions studied: Chronic Spontaneous Urticaria
In brief
The purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) who completed the treatment and follow-up periods of the Phase 3 clinical trials. This study will also fulfill the Celldex commitment to provide post-trial access to participants who have completed the phase 3 studies, where applicable.
Key facts
- Study ID
- NCT07256392
- Run by
- Celldex Therapeutics
- People needed
- 1370
- Starts
- 2025-11-25
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medical Research of Arizona — Scottsdale, Arizona, United States
- Center for Dermatology & Plastic Surgery - Avacare — Scottsdale, Arizona, United States
- Kern Research — Bakersfield, California, United States
- Allergy and Asthma Associates of Southern California - Laguna Niguel - CRN — Laguna Niguel, California, United States
- Dermatology Research Associates — Los Angeles, California, United States
- LA Universal Research Center, Inc. — Los Angeles, California, United States
- Encore Medical Research of Boynton Beach LLC — Boynton Beach, Florida, United States
- Dolphin Medical Research — Doral, Florida, United States
- Direct Helpers Research Center — Hialeah, Florida, United States
- Deluxe Health Center — Miami Lakes, Florida, United States
- Sarasota Clinical Research — Sarasota, Florida, United States
- GCP, Global Clinical Professionals — St. Petersburg, Florida, United States
- Advanced Clinical Research Institute (ACRI) - Florida — Tampa, Florida, United States
- Centricity Research Columbus Dermatology — Columbus, Georgia, United States
- Endeavor Health — Skokie, Illinois, United States
- The South Bend Clinic - Avacare — South Bend, Indiana, United States
- John Hopkins University — Baltimore, Maryland, United States
- Institute for Asthma and Allergy — Wheaton, Maryland, United States
- Michigan Center for Research Co., LLC — Clarkston, Michigan, United States
- Respiratory Medicine Research Institute of Michigan PLC — Ypsilanti, Michigan, United States
- Midwest Clinical Research — St Louis, Missouri, United States
- Montana Medical Research, Inc. — Missoula, Montana, United States
- Markowitz Medical PLLC dba OptiSkin Medical — New York, New York, United States
- Bexley Dermatology Research — Bexley, Ohio, United States
- Cahaba Dermatology & Skin Health Center, LLC — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.